Subscribe
After parting ways with its chief executive, the Danish pharmaceutical company needs to revive its appeal
News and updates on your investments
The numbers aren鈥檛 there yet, but AI advances are still helping justify their lofty ratings
A stormy AGM season highlights how bumper pay packages are irritating investors
Jakob Stausholm took the top job to steady the ship and leaves after almost five years in the role
A step change in fiscal policy has boosted a range of contractors
Kounrad owner to spend $119mn on ASX-listed copper company with Arizona project
